Literature DB >> 132862

A general cardiovascular risk profile: the Framingham Study.

W B Kannel, D McGee, T Gordon.   

Abstract

Persons at high risk of cardiovascular disease can be effectively identified from a measurement of their serum cholesterol and blood pressure, a smoking history, an electrocardiogram and a determination of glucose intolerance. One general function for identifying persons at high risk of cardiovascular disease is also effective in identifying persons at risk for each of the specific diseases, coronary heart disease, atherothrombotic brain infarction, hypertensive heart disease and intermittent claudication, even though the variables used have a different impact on each particular disease. The 10 percent of persons identified with use of this function as at highest risk accounted for about one fifth of the 8 year incidence of coronary heart disease and about one third of the 8 year incidence of atherothrombotic brain infarction, hypertensive heart disease and intermittent claudication. Hence the function provides an economic and efficient method of identifying persons at high cardiovascular risk who need preventive treatment and persons at low risk who need not be alarmed about one moderately elevated risk characteristic.

Entities:  

Mesh:

Year:  1976        PMID: 132862     DOI: 10.1016/0002-9149(76)90061-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  206 in total

1.  Aptitude for physical exercise in a population of female hospital workers.

Authors:  M Estryn-Behar; B Kapitaniak; M C Paoli; E Peigne; A Masson
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

2.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

3.  Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk.

Authors:  Deborah E Barnes; Kenneth E Covinsky; Rachel A Whitmer; Lewis H Kuller; Oscar L Lopez; Kristine Yaffe
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

Review 4.  Brain health and shared risk factors for dementia and stroke.

Authors:  Hannah Gardener; Clinton B Wright; Tatjana Rundek; Ralph L Sacco
Journal:  Nat Rev Neurol       Date:  2015-10-20       Impact factor: 42.937

5.  Estimation of Hardy-Weinberg and pairwise disequilibrium in the apolipoprotein AI-CIII-AIV gene cluster.

Authors:  M B Haviland; A M Kessling; J Davignon; C F Sing
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

6.  Cardiac risk factors in patients with diabetes mellitus and major depression.

Authors:  Wayne J Katon; Elizabeth H B Lin; Joan Russo; Michael Von Korff; Paul Ciechanowski; Greg Simon; Evette Ludman; Terry Bush; Bessie Young
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

Review 7.  Risk assessment models to estimate cancer probabilities.

Authors:  Constance M Johnson; Derek Smolenski
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

8.  Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen.

Authors:  Eric Thorin; Mylan Pham-Dang; Robert Clement; Isabelle Mercier; Angelino Calderone
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

9.  Sex differences in vascular and endothelial responses to acute mental stress.

Authors:  Elizabeth A Martin; Shen-Li Tan; Leslie R MacBride; Shahar Lavi; Lilach O Lerman; Amir Lerman
Journal:  Clin Auton Res       Date:  2008-10-11       Impact factor: 4.435

10.  Stress single photon emission computed tomography for detection of coronary artery disease and risk stratification of asymptomatic patients at moderate risk.

Authors:  Masud H Khandaker; Todd D Miller; Panithaya Chareonthaitawee; J Wells Askew; David O Hodge; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2009-05-14       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.